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Abstract
Background: Control of rubella infection is essential for preventing congenital rubella syndrome (CRS) and one of
the important steps is to define a target population for vaccination. Therefore this study was done to determine
serological evidence of acute rubella infection among under-fives in order to anticipate the magnitude of rubella
virus transmission in Tanzania.
Methods: A cross-sectional study involving children aged between 1 and 59 months was conducted between
September and October 2014 before national rubella vaccination campaigns commenced. Rubella IgM antibodies
were detected using commercial indirect enzyme-linked immunosorbent assay (ELISA). Data were analyzed using
STATA version 11.
Results: A total of230 under-fives were enrolled, their median age was 14 (Interquartile range (IQR) 7–26) months.
The overall seroprevalence of rubella IgM antibodies was 10.9 % (25/230) with two confirmed cases of CRS. Two-sample
Wilcoxon rank-sum test showed that the median age of rubella IgM seropositive children was significantly higher than
that of IgM seronegative children (39 IQR: 18-51months vs. 14 IQR: 7–24 months, P < 0.001). On multivariate logistic
regression analysis increase in age (OR: 1.07, 95 % CI; 1.03–1.1, P < 0.001) and residing in rural areas (OR: 8.07, 95 % CI; 1.
43–45.6, P = 0.018) were independently found to predict acute rubella infection among under-fives.
Conclusion: Our findings indicate that rubella virus is prevalent in our setting posing a risk of transmitting to childbearing
aged women hence increasing the risk of CRS. Increasing prevalence of acute infection with age in under-fives indicates
the protective role of maternal antibodies among infants. The sustained vaccination programme of under-fives as
effective measure to control CRS should be emphasized in developing countries.
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Background
Rubella is a mild childhood illness transmitted through
aerosol or direct contact. The disease affects mostly chil-
dren, young adults, women of child bearing age and preg-
nant women [1]. It is common in many resource-
constrained countries where vaccination has not yet been
introduced. Rubella infection may present as an acute,
mild or asymptomatic illness; therefore the outbreaks may
occur without clinical recognition or may be misdiagnosed
as measles cases [2, 3]. This poses difficulties for its clin-
ical diagnosis, therefore serological tests for detection of
specific rubella antibodies in suspected cases remains to
be important [4]. In most cases, the disease is self-limiting
and rarely causes complications in children. However, if
contracted during the first trimester of pregnancy rubella
virus may become a potential teratogenic agent which re-
sults into multiple organ defects referred to as the congeni-
tal rubella syndrome (CRS). More than 100,000 children
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are born with CRS each year especially in resource-
constrained countries [3, 5, 6]. The majority of adolescents
and women of child bearing age show high rubella sero-
positivity rates due to childhood exposure. Children usually
harbour and spread the infection in a community including
pregnant women which pose the risk to increasing rates of
CRS [7]. Tanzania is among sub Saharan African country
where rubella vaccine has been recently introduced and
there are only few reports [8–11] on rubella; therefore the
magnitude of rubella infection is unknown. This study
was conducted to assess the magnitude of acute rubella
infection among under-fives in order to understand the
potential risk of transmitting to adults including preg-
nant women.
Methods
A cross sectional hospital based study was carried out
between end of September and October 2014 involving
urban and rural settings of Mwanza city having a total
population of about 7,064,453 [12]. The data were col-
lected just before the national rubella vaccination cam-
paign commenced in October 2014.
Sample size and sampling procedures
The sample size was calculated using Kish Lisle formula
of cross-sectional study. The prevalence of 31 % among
under-fives from the study in Jos Nigeria was used [13].
The minimum sample size obtained was 226 under-
fives. Three reproductive and child health clinics (RCH)
representing urban and rural settings of Mwanza city
were conveniently selected. Under-fives were serially and
proportionally enrolled from Makongoro and Bugando
(urban); and Karume (rural) until the desired sample size
was reached.
Data collection and laboratory procedures
After obtaining written informed consent from parent/
guardian, 2 – 4 ml of blood samples were collected using
plain vacutainer tubes (Becton Dickinson, Nairobi, Kenya)
and transported to the Bugando multipurpose laboratory
whereby sera were separated and stored in cryovials at
−80 °C freezer until the time for processing. Standardized
data collection tool was used to obtain social demographic
information and the presence or absence of rashes was
noted. Data collected included age, sex, residence, socio-
economic status, number of siblings, and presence of
rashes or family member with rash. Good social economic
status was defined as parents being educated (secondary
education and above) with sustainable income (>1USD/
day) or income generating activities such as tailoring, fish-
ing, petty business etc.
Laboratory investigations
Sera were tested for presence of specific IgM usingcom-
mercial indirect enzyme-linked immunosorbent assay
(ELISA) (ChemWell® 2910-Awareness Technology Inc.,
Palm City, USA) according to the manufacturer’s in-
structions with the positive cut off values of ≥ 1 index.
ELISA has been found to be a reliable method for assay-
ing rubella antibodies with sensitivity and specificity of
>97 % [14].
Data management and analysis
Data were entered into a computer using Microsoft Of-
fice Excel 2007 and analyzed using the STATA version
11 (College Station, Texas, USA). Categorical variables
were presented as proportions and analyzed using the
Pearson’s Chi-square to observe the differences among
the various groups. Continuous variables were summa-
rized as median with interquartile ranges. Univariate
analysis and multivariate logistic regression models were
fitted to determine factors associated with rubella IgM
seropositivity. We used a backward-stepwise selection
model to select factors with a p-value <0.5 to be fitted
into the multivariate logistic regression analysis. Odds
ratio (OR) and 95 % confidence interval [95 % CI] were
presented.
Ethical clearance
The protocol for conducting the study was approved by
the Joint Catholic University of Health and Allied Sci-
ences/Bugando Medical Centre (CUHAS/BMC) research
ethics and review committee. Permission was sought
from hospital/clinics administration. Written informed
consent was obtained from each parent/guardian prior
recruitment to the study. All under-fives with acute in-




A total number of 230 under-fives were enrolled with the
median age of 14 (Interquartile range (IQR) 7–26) months.
Age distribution of under-fives were 90 (39 %), 68 (29 %),
32 (13.9 %), 13 (5.6 %) and 27 (11.7 %) for 0–11, 12–23,
24–35, 36–47 and 48–59 months respectively. Of the 230
under-fives, 65 (28.3 %), 118 (51.3 %) and 47 (20.4 %) were
enrolled from Bugando Medical Centre- pediatric outpa-
tients Department, Karume and Makongoro clinics, re-
spectively. A total of 86 (37.4 %) and 144 (62.6 %) were
residing in urban and rural areas, respectively. A total
number of 166 (72.2 %) and 64 (27.8 %) were from families
with good and poor socio-economic status, respectively.
Of the under-fives, 116 (50.4 %) and 114 (49.6 %) were
females and males respectively. There was no significant
difference in the median number of siblings between the
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children residing in rural and those residing in urban areas
(2; IQR:2–3 vs. 2;IQR:2–4, P > 0.05).
Prevalence of rubella-specific IgM antibodies and
associated factors
Overall, seroprevalence of rubella IgM antibodies was
10.9 % (25/230) with median index value of 1.4: IQR:
1.2–2.5. The median age for IgM seropositive children
was 39 (IQR: 18–51) months while that of IgM sero-
negative was 14 (IQR:7–24) months and the difference
was statistically significant (P < 0.001). The rubella IgM
seroprevalence was 3 (3.3 %), 7 (10.3 %), 2 (6.3 %), 5
(38.5 %) and 8 (29.6 %) among children aged 0–11, 12–23,
24–35, 36–47 and 48–59 months, respectively (Fig. 1). The
seroprevalence of rubella IgM was found to increase signifi-
cantly as the age increases (OR: 1.05 95 % CI: 1.03–1.08,
P < 0.001). On univariate analysis; as the number of sib-
lings increases the seroprevalence of rubella IgM tends
to decrease significantly (OR: 0.6 95 % CI: 0.36–0.99,
P = 0.044). The risk of having acute rubella infection was
higher among under-fives presented with rash. However
the level of significance was borderline (OR:2.18, 95 % CI:
0.92–5.17, P = 0.07).On multivariate logistic regression ana-
lysis, increase in age by a month and residing in rural areas
were found to be independent predictors of having acute
rubella infection (Table 1).
Clinical assessment of IgM positive children
Out of 25 IgM positive under-fives 3 were infants. Of 3
infants, 2 (one at 4 months and another at 6 months)
were confirmed to have features of CRS both had con-
genital heart defects and congenital cataracts.
Discussion
Control of rubella infection is crucial for eliminating
CRS. However, the control should be strategic and cost
effective to achieve a milestone of preventing CRS. One
of the strategies to accomplish this is to define the target
population for vaccination and maintain surveillance of
CRS. There are few reports on acute rubella infection
among under-fives in Africa [7]. This study for the first
time in Tanzania provides information regarding acute
rubella infection among under-fives; the group that can
be source of infection to pregnant women.
The seroprevalence of acute rubella infection among the
under-fives was found to be comparable with previous
study in India [15] but significantly higher compared to
another study which was done a year later in India among
pediatric population before vaccination era [16]. However,
the magnitude of acute infection among under-fives in the
current study is lower than that reported from Nigeria
among under-fives [13]. Given the fact that in developed
countries a single rubella case is considered as a potential
risk for transmitting rubella virus to pregnant women
which may results into poor pregnancy outcome; the
reported prevalence in this study is indeed high [17].
This is further supported by our findings whereby 2 out
230 under-fives in the current study were confirmed to
have CRS.
Previous studies in the same setting observed high
prevalence of natural immunity against rubella virus
among pregnant women [11, 18]. Maternal rubella anti-
bodies have been found to provide protection against
acute rubella infection in the first six months of life.
The role of maternal antibodies in the protection of
acute rubella infection was confirmed in the current
study as evidenced by the fact that as the age increases
Fig. 1 Age specific prevalence of rubella IgM antibodies among under-5 children in Mwanza city
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the risk of having acute rubella infection was found to
increase significantly [19].
Children residing in rural areas were found to be at
high risk of having acute rubella infection as compared
to the urban group. Most of houses in the rural areas of
Mwanza are not well ventilated hence pose a potential
risk for transmitting airborne diseases as previously doc-
umented [20]. In the current study though not signifi-
cant on multivariate analysis; as the number of siblings
increases the risk of having acute rubella infection de-
creases. Due to the nature of the disease high transmis-
sion rates occurs in congested areas. Therefore; children
from households with high number of siblings might
have previously exposed to rubella viruses therefore they
are naturally protected [17, 21–23].
Conclusion
In conclusion acute rubella infection among under-fives
in Mwanza is high with about one out of 100 under-
fives having CRS. Among under-fives increase in age
and residing in rural areas were independent factors pre-
dicting acute rubella infection. Acute rubella infection
among under-fives poses a potential risks to susceptible
pregnant women which often results into poor preg-
nancy outcome including CRS. The findings support the
current programme of vaccinating all under-fives. In
addition; screening and vaccinating susceptible child-
bearing aged women should be considered in developing
countries in efforts to control CRS.
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